Protocol digest of randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan clinical oncology group study (JCOG1407)
about
Protocol digest of randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan clinical oncology group study (JCOG1407)
description
im Juli 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 27 July 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Protocol digest of randomized ...... ncology group study (JCOG1407)
@en
Protocol digest of randomized ...... clinical oncology group study
@nl
type
label
Protocol digest of randomized ...... ncology group study (JCOG1407)
@en
Protocol digest of randomized ...... clinical oncology group study
@nl
prefLabel
Protocol digest of randomized ...... ncology group study (JCOG1407)
@en
Protocol digest of randomized ...... clinical oncology group study
@nl
P2093
P1433
P1476
Protocol digest of randomized ...... ncology group study (JCOG1407)
@en
P2093
Akira Fukutomi
Haruhiko Fukuda
Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group
Hideki Ueno
Hiroshi Ishii
Hiroshi Katayama
Junji Furuse
Junki Mizusawa
Makoto Ueno
Masafumi Ikeda
P304
P356
10.1016/J.PAN.2018.07.007
P407
P577
2018-07-27T00:00:00Z